Balance Sheet

Current Liabilities	72.6m
Accounts Payable	7.6m
Accrued Liabilities	13.5m
Other Current Liabilities	51.4m
Non-Current Liabilities	56.2m
Other Non-Current Liabilities	56.2m

Currency: USD

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	7	31	37	32	47	86	104	117	99	69
Cash Equivalents	7	31	37	32	47	86	104	117	99	69
Short-Term Investments	0	163	138	138	109	196	77	15	20	162
Total Receivables	0	0	0	0	0	19	8	1	1	84
Accounts Receivables	0	0	0	0	0	19	8	1	0	83
Other Receivables	0	0	0	0	0	1	0	0	0	1
Other Current Assets	1	1	4	3	7	4	9	3	5	4
Total Current Assets	8	196	179	172	163	305	198	137	125	320
PP&E Net	3	3	8	10	13	47	62	55	33	30
PP&E Gross	3	3	8	10	13	47	62	55	33	30
Accumulated Depreciation	0	1	1	3	5	8	12	16	17	15
Long-Term Investments	0	30	1	1	1	2	0	0	0	0
Other Long-Term Assets	0	0	2	1	1	2	2	2	2	2
Total Assets	12 N/A	230 +1 896%	190 -17%	185 -3%	177 -4%	355 +100%	262 -26%	194 -26%	159 -18%	351 +120%
Liabilities
Accounts Payable	2	1	1	1	1	4	1	1	3	2
Accrued Liabilities	1	3	7	12	10	25	18	20	11	20
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	20	7	3	21	47	8	31	59	43
Total Current Liabilities	3	24	14	16	32	76	27	51	73	65
Long-Term Debt	6	0	0	0	0	0	0	0	0	0
Other Liabilities	2	37	40	35	99	179	81	48	28	50
Total Liabilities	10 N/A	60 +486%	54 -11%	50 -6%	131 +159%	255 +95%	107 -58%	99 -8%	100 +2%	115 +15%
Equity
Common Stock	22	0	0	0	0	0	0	0	0	0
Retained Earnings	21	50	90	161	269	313	276	347	394	261
Additional Paid In Capital	0	219	226	295	316	412	430	442	453	498
Other Equity	0	0	0	0	0	0	0	0	0	0
Total Equity	1 N/A	169 +15 273%	136 -20%	134 -1%	46 -65%	100 +114%	154 +55%	95 -38%	59 -38%	236 +301%
Total Liabilities & Equity	12 N/A	230 +1 896%	190 -17%	185 -3%	177 -4%	355 +100%	262 -26%	194 -26%	159 -18%	351 +120%
Shares Outstanding
Common Shares Outstanding	26	26	26	32	32	37	37	38	39	44

Voyager Therapeutics Inc
NASDAQ:VYGR